Tavi Switzerland
Reviewed by the SwissAtlas coordination team · Last updated:
Diagnostic versus interventional pathway distinction guides the way families prepare high-stakes decisions under cross-border pressure.
Reviewed by the SwissAtlas coordination team · Last updated:
Diagnostic versus interventional pathway distinction guides the way families prepare high-stakes decisions under cross-border pressure.
TAVI indication is confirmed by a Heart Team — a formal multidisciplinary meeting including an interventional cardiologist, cardiac surgeon, imaging cardiologist, and anaesthesiologist. Risk scoring using STS and EuroSCORE II, combined with anatomical assessment via CT angiography, determines procedural approach and prosthesis selection. The transfemoral route is used in approximately 90% of cases; alternative access is reserved for patients with inadequate femoral anatomy.
Cardiology treatment in Switzerland is guided by standards supported by the Swiss Heart Foundation.
The core TAVI indication is severe symptomatic aortic stenosis, typically defined by mean gradient above 40 mmHg or valve area below 1 cm2 in the context of full echocardiographic assessment. Symptom burden, ventricular function, and comorbidity architecture all influence timing decisions. Families should request explicit correlation between imaging severity and clinical presentation before approving any procedure.
SwissAtlas supports international families navigating complex medical situations with discretion and clarity. Each case is handled with strict confidentiality and a structured coordination approach. Designed for sensitive situations requiring discretion and clarity.
TAVI is performed in a hybrid catheter laboratory or cardiac surgery theatre under conscious sedation in most cases. Procedure duration is typically one to two hours. Post-procedural monitoring covers arrhythmia detection, access-site management, and valve function assessment. Standard hospitalisation runs three to five days, with discharge contingent on rhythm stability and ambulation clearance. Total in-country stay planning for international families should account for pre-procedural workup, the procedure, and post-procedural observation — typically seven to ten days.
TAVI scheduling requires: recent transthoracic echocardiogram (within three months), CT thoracic angiography with contrast for anatomical planning, 12-lead ECG, full blood work including renal function and coagulation, and a complete cardiac history covering prior interventions, device implants, and current medications. Incomplete documentation delays Heart Team scheduling, which delays the entire pathway. For international files, assembling complete documentation before any travel is arranged is the single most time-efficient step families can take.
TAVI in Swiss private centres typically costs CHF 35,000–70,000 covering the procedure, prosthesis, catheter laboratory, cardiac surgery backup, anaesthesia, and inpatient stay. Cost variation within this range reflects prosthesis selection (next-generation devices carry higher implant costs), access route complexity, and hospitalisation duration. Families should request an itemised estimate inclusive of all components rather than a bundled procedure price, and should clarify what triggers additional cost — post-procedural complications, pacemaker implantation if required, extended monitoring.
Post-TAVI follow-up is structured: transthoracic echocardiography at 30 days, 12 months, and annually thereafter to monitor valve function and detect structural valve deterioration. Antiplatelet and anticoagulation management requires coordination between the Swiss cardiac team and the patient's home-country cardiologist. Families should ensure that the Swiss centre provides a detailed medication protocol and follow-up plan in a format that any cardiologist can implement without requiring clarification calls to Switzerland.
SwissAtlas operates exclusively as a non-medical coordination platform. We do not provide clinical services, diagnoses, or treatment recommendations. All medical decisions are made by licensed Swiss institutions.
The pre-TAVI workup requires a CT angiography of the aorta and iliofemoral vessels — this is the imaging study that determines vascular access feasibility and guides device sizing. If this CT has been performed recently (within three months) at adequate quality, it can be shared with the Swiss centre for remote review before travel is arranged. If it has not been performed or is of insufficient quality, it must be completed in Switzerland before the Heart Team can confirm the procedural plan. This single imaging study is often the critical path item in international TAVI planning.
Families should budget for a minimum of seven to ten days in Switzerland: two to three days for pre-procedure assessment, one to two days for the procedure itself, and three to five days of post-procedural monitoring and mobilisation before discharge clearance. Patients with complications — rare in experienced centres but possible — will have longer stays. Return travel should not be booked until the treating cardiologist has confirmed discharge; most TAVI teams will not clear a patient for long-haul flight for a minimum of five to seven days post-procedure.
Anticoagulation and antiplatelet management after TAVI requires coordination with a cardiologist in the home country. The Swiss centre will provide a specific antiplatelet protocol (typically dual antiplatelet therapy for three to six months); ensuring this protocol is understood by the home cardiologist before departure is the most important single element of post-procedure continuity. The discharge summary should be translated into the language of the home-country treating physician if necessary — this is a coordination task SwissAtlas manages as standard.
SwissAtlas coordinates non-clinical sequencing, documentation flow, and logistics governance while licensed institutions retain medical decision authority.
Records should be assembled as chronology with unresolved questions so specialist review can proceed without avoidable interpretation gaps.
Budgets should be scenario-based because pathway scope can evolve after deeper institutional evidence review.
Confidentiality is strengthened by role-based recipient controls and approved channels defined before high-sensitivity updates begin.
Timelines are safer when logistics commitments are tied to confirmed milestones rather than assumptions made before candidacy is established.
Confidential access to private medical care in Switzerland.
SwissAtlas operates at the intersection of discretion, structure, and access. Unlike traditional intermediaries, we do not promote specific clinics or treatments. Our role is to provide a neutral, structured, and confidential coordination layer for international patients navigating complex medical situations. This approach allows families to move forward with clarity, without pressure, and without exposure.
SwissAtlas is designed for: international families seeking discretion; patients requiring fast and structured access; situations where clarity and confidentiality are essential.
No medical advice. No pressure. Only structured coordination.
For the complete strategic framework, review medical travel in Switzerland, treatment in Switzerland for international patients, and private healthcare Switzerland.